- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Marlborough Today
By the People, for the People
Legal & General Group Plc Boosts Stake in Boston Scientific Corporation
Investment firm increases ownership in medical device maker by 4.6% in Q3 2025
Published on Mar. 10, 2026
Got story updates? Submit your updates here. ›
Legal & General Group Plc, a major institutional investor, increased its stake in Boston Scientific Corporation (NYSE:BSX) by 4.6% in the third quarter of 2025, according to a recent SEC filing. The firm now owns approximately 10.5 million shares, or 0.71% of the medical equipment provider's outstanding stock, valued at over $1 billion.
Why it matters
This investment move by Legal & General Group, one of the world's largest asset managers, signals continued confidence in Boston Scientific's long-term growth prospects despite recent legal and regulatory challenges facing the company. The increased stake could provide a boost to Boston Scientific's share price and overall market valuation.
The details
According to the filing, Legal & General Group purchased an additional 463,889 shares of Boston Scientific in the third quarter, bringing its total ownership to 10,457,175 shares. This represents a 4.6% increase in the firm's position. The investment is part of Legal & General's broader strategy to maintain exposure to leading medical device companies like Boston Scientific, which develops a range of cardiovascular, digestive, and other minimally invasive products.
- Legal & General Group Plc increased its stake in Boston Scientific in the third quarter of 2025.
The players
Legal & General Group Plc
A major global investment management firm headquartered in the United Kingdom.
Boston Scientific Corporation
A leading medical device company that develops and manufactures a broad portfolio of products used in minimally invasive medical procedures.
The takeaway
Legal & General Group's increased stake in Boston Scientific demonstrates the investment firm's confidence in the medical device maker's long-term prospects, despite recent legal and regulatory challenges. This move could provide a boost to Boston Scientific's share price and market valuation as the company navigates these issues.
